Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2742 | 2160 | 28.9 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
321 | 3 | VIROLOGY//FOOT AND MOUTH DISEASE//CORONAVIRUS | 39123 |
745 | 2 | FOOT AND MOUTH DISEASE//FOOT AND MOUTH DISEASE VIRUS//ENTEROVIRUS 71 | 12488 |
2742 | 1 | POLIOMYELITIS//POLIOVIRUS//POLIO ERADICATION | 2160 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | POLIOMYELITIS | authKW | 1065862 | 9% | 39% | 194 |
2 | POLIOVIRUS | authKW | 751114 | 8% | 29% | 183 |
3 | POLIO ERADICATION | authKW | 683042 | 3% | 79% | 61 |
4 | POLIO | authKW | 579183 | 5% | 41% | 100 |
5 | VACCINE DERIVED POLIOVIRUS | authKW | 480979 | 2% | 97% | 35 |
6 | ORAL POLIOVIRUS VACCINE | authKW | 475202 | 2% | 82% | 41 |
7 | INACTIVATED POLIOVIRUS VACCINE | authKW | 443702 | 2% | 83% | 38 |
8 | GLOBAL IMMUNIZAT | address | 396040 | 4% | 30% | 95 |
9 | POLIO ERADICAT | address | 329485 | 1% | 90% | 26 |
10 | ORAL POLIO VACCINE | authKW | 304607 | 2% | 57% | 38 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 16359 | 21% | 0% | 457 |
2 | Infectious Diseases | 8032 | 19% | 0% | 402 |
3 | Immunology | 6416 | 27% | 0% | 584 |
4 | Microbiology | 4577 | 20% | 0% | 435 |
5 | Public, Environmental & Occupational Health | 3546 | 18% | 0% | 378 |
6 | BIOLOGY, MISCELLANEOUS | 1090 | 1% | 1% | 11 |
7 | Tropical Medicine | 1035 | 3% | 0% | 75 |
8 | Medicine, Research & Experimental | 1000 | 9% | 0% | 196 |
9 | Biotechnology & Applied Microbiology | 818 | 10% | 0% | 207 |
10 | Medicine, General & Internal | 735 | 10% | 0% | 217 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GLOBAL IMMUNIZAT | 396040 | 4% | 30% | 95 |
2 | POLIO ERADICAT | 329485 | 1% | 90% | 26 |
3 | POLIO SURVEILLANCE PROJECT | 254417 | 1% | 75% | 24 |
4 | GLOBAL POLIO ERADICAT INITIAT | 228983 | 1% | 90% | 18 |
5 | POLIO ERADICAT INITIAT | 163389 | 1% | 68% | 17 |
6 | COUNTRY REP ENTAT OFF | 157318 | 1% | 70% | 16 |
7 | ENTEROVIRUS | 106107 | 2% | 23% | 33 |
8 | KIDS RISK PROJECT | 100958 | 0% | 71% | 10 |
9 | POLIO | 88066 | 0% | 69% | 9 |
10 | POLIO ERADICAT BRANCH | 88066 | 0% | 69% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REVIEWS OF INFECTIOUS DISEASES | 28004 | 3% | 3% | 71 |
2 | BIOLOGICALS | 25906 | 2% | 4% | 50 |
3 | BULLETIN OF THE WORLD HEALTH ORGANIZATION | 24513 | 4% | 2% | 77 |
4 | JOURNAL OF INFECTIOUS DISEASES | 22524 | 8% | 1% | 168 |
5 | DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION | 21991 | 1% | 5% | 30 |
6 | MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 19222 | 2% | 4% | 37 |
7 | VACCINE | 19154 | 7% | 1% | 157 |
8 | DEVELOPMENTS IN BIOLOGICALS | 15635 | 1% | 9% | 12 |
9 | PROGRESS IN MEDICAL VIROLOGY | 9217 | 0% | 7% | 9 |
10 | JOURNAL OF GENERAL VIROLOGY | 6333 | 4% | 1% | 78 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | POLIOMYELITIS | 1065862 | 9% | 39% | 194 | Search POLIOMYELITIS | Search POLIOMYELITIS |
2 | POLIOVIRUS | 751114 | 8% | 29% | 183 | Search POLIOVIRUS | Search POLIOVIRUS |
3 | POLIO ERADICATION | 683042 | 3% | 79% | 61 | Search POLIO+ERADICATION | Search POLIO+ERADICATION |
4 | POLIO | 579183 | 5% | 41% | 100 | Search POLIO | Search POLIO |
5 | VACCINE DERIVED POLIOVIRUS | 480979 | 2% | 97% | 35 | Search VACCINE+DERIVED+POLIOVIRUS | Search VACCINE+DERIVED+POLIOVIRUS |
6 | ORAL POLIOVIRUS VACCINE | 475202 | 2% | 82% | 41 | Search ORAL+POLIOVIRUS+VACCINE | Search ORAL+POLIOVIRUS+VACCINE |
7 | INACTIVATED POLIOVIRUS VACCINE | 443702 | 2% | 83% | 38 | Search INACTIVATED+POLIOVIRUS+VACCINE | Search INACTIVATED+POLIOVIRUS+VACCINE |
8 | ORAL POLIO VACCINE | 304607 | 2% | 57% | 38 | Search ORAL+POLIO+VACCINE | Search ORAL+POLIO+VACCINE |
9 | INACTIVATED POLIO VACCINE | 301841 | 1% | 69% | 31 | Search INACTIVATED+POLIO+VACCINE | Search INACTIVATED+POLIO+VACCINE |
10 | VACCINE ASSOCIATED PARALYTIC POLIOMYELITIS | 212024 | 1% | 100% | 15 | Search VACCINE+ASSOCIATED+PARALYTIC+POLIOMYELITIS | Search VACCINE+ASSOCIATED+PARALYTIC+POLIOMYELITIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KEW, OM , SUTTER, RW , DE GOURVILLE, EM , DOWDLE, WR , PALLANSCH, MA , (2005) VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION.ANNUAL REVIEW OF MICROBIOLOGY. VOL. 59. ISSUE . P. 587 -635 | 116 | 85% | 301 |
2 | PLIAKA, V , KYRIAKOPOULOU, Z , MARKOULATOS, P , (2012) RISKS ASSOCIATED WITH THE USE OF LIVE-ATTENUATED VACCINE POLIOVIRUS STRAINS AND THE STRATEGIES FOR CONTROL AND ERADICATION OF PARALYTIC POLIOMYELITIS.EXPERT REVIEW OF VACCINES. VOL. 11. ISSUE 5. P. 609-628 | 128 | 76% | 17 |
3 | TEBBENS, RJD , PALLANSCH, MA , KIM, JH , BURNS, CC , KEW, OM , OBERSTE, MS , DIOP, OM , WASSILAK, SGF , COCHI, SL , THOMPSON, KM , (2013) ORAL POLIOVIRUS VACCINE EVOLUTION AND INSIGHTS RELEVANT TO MODELING THE RISKS OF CIRCULATING VACCINE-DERIVED POLIOVIRUSES (CVDPVS).RISK ANALYSIS. VOL. 33. ISSUE 4. P. 680-702 | 102 | 96% | 7 |
4 | GRASSLY, NC , (2013) THE FINAL STAGES OF THE GLOBAL ERADICATION OF POLIOMYELITIS.PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. VOL. 368. ISSUE 1623. P. - | 82 | 95% | 20 |
5 | BURNS, CC , DIOP, OM , SUTTER, RW , KEW, OM , (2014) VACCINE-DERIVED POLIOVIRUSES.JOURNAL OF INFECTIOUS DISEASES. VOL. 210. ISSUE . P. S283 -S293 | 59 | 95% | 40 |
6 | THOMPSON, KM , PALLANSCH, MA , TEBBENS, RJD , WASSILAK, SG , KIM, JH , COCHI, SL , (2013) PREERADICATION VACCINE POLICY OPTIONS FOR POLIOVIRUS INFECTION AND DISEASE CONTROL.RISK ANALYSIS. VOL. 33. ISSUE 4. P. 516-543 | 70 | 95% | 2 |
7 | TEBBENS, RJD , PALLANSCH, MA , CHUMAKOV, KM , HALSEY, NA , HOVI, T , MINOR, PD , MODLIN, JF , PATRIARCA, PA , SUTTER, RW , WRIGHT, PF , ET AL (2013) EXPERT REVIEW ON POLIOVIRUS IMMUNITY AND TRANSMISSION.RISK ANALYSIS. VOL. 33. ISSUE 4. P. 544-605 | 66 | 96% | 7 |
8 | NATHANSON, N , KEW, OM , (2010) FROM EMERGENCE TO ERADICATION: THE EPIDEMIOLOGY OF POLIOMYELITIS DECONSTRUCTED.AMERICAN JOURNAL OF EPIDEMIOLOGY. VOL. 172. ISSUE 11. P. 1213 -1229 | 52 | 96% | 96 |
9 | COMBELAS, N , HOLMBLAT, B , JOFFRET, ML , COLBERE-GARAPIN, F , DELPEYROUX, F , (2011) RECOMBINATION BETWEEN POLIOVIRUS AND COXSACKIE A VIRUSES OF SPECIES C: A MODEL OF VIRAL GENETIC PLASTICITY AND EMERGENCE.VIRUSES-BASEL. VOL. 3. ISSUE 8. P. 1460-1484 | 72 | 75% | 31 |
10 | FRIEDRICH, F , (1998) NEUROLOGIC COMPLICATIONS ASSOCIATED WITH ORAL POLIOVIRUS VACCINE AND GENOMIC VARIABILITY OF THE VACCINE STRAINS AFTER MULTIPLICATION IN HUMANS.ACTA VIROLOGICA. VOL. 42. ISSUE 3. P. 187 -194 | 95 | 91% | 5 |
Classes with closest relation at Level 1 |